Related Experiment Video
Updated: Feb 24, 2026
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
15.6K
Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma
Akira Shimizu1, Kyoichi Kaira1, Yuko Okubo1
1and Gunma University Graduate School of Medicine, Maebashi, Gunma; and and Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan.
Journal of Global Oncology
|August 24, 2017
Summary
Programmed death-ligand 1 (PD-L1) expression in cutaneous angiosarcoma (CA) is linked to worse patient outcomes. This study identifies PD-L1 as a novel prognostic marker for CA, highlighting its clinical significance.
Area of Science:
- Oncology
- Immunology
- Dermatopathology
Background:
- Programmed death-1 (PD-1) and PD-L1 targeted therapies show survival benefits in various cancers.
- The correlation between PD-L1 expression and clinical/pathological factors in cutaneous angiosarcoma (CA) remains largely uncharacterized.
Purpose of the Study:
- To investigate the clinicopathological significance of PD-L1 expression in patients diagnosed with cutaneous angiosarcoma.
- To determine if PD-L1 expression correlates with specific clinical and pathological variables in CA.
Main Methods:
- Retrospective review of data from 52 cutaneous angiosarcoma patients.
- Immunohistochemical analysis of PD-L1 expression, Ki-67 proliferation index, and tumor-infiltrating lymphocytes (CD4+, CD8+).
- Correlation analysis with clinicopathological variables.
Main Results:
- PD-L1 expression was observed in 40% of the CA patient cohort.
- PD-L1 expression demonstrated a significant association with increased tumor cell proliferation.
- High CD8+ tumor-infiltrating lymphocytes predicted better outcomes in stage I CA, while PD-L1 positivity independently predicted a worse prognosis.
Conclusions:
- PD-L1 expression emerges as a novel pathological marker for predicting adverse outcomes in cutaneous angiosarcoma patients.
- The findings suggest PD-L1 status is a significant prognostic indicator in CA.
